Patent Assignment
Reel/Frame 034018/0432
Assignment of Security Interest
Recorded: 2014-10-20
Pages: 6
Assignor
KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Executed: 2014-10-17
Assignee
VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
2150 BOUL. ST-ELZÉAR OUEST, LAVAL, QUEBEC, H7L 4A8, CANADA
Covered Property
(1)
Method of Reducing Somnolence in Patients Treated with Tizanidine
Patent:
6,455,557 →
Application:
09/994,837 →
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 3, 2002
From: PELLEGRINI, CARA A.; STARK, PAUL
To: ELAN PHARMACEUTICALS, INC.
Reel/Frame 013059/0082 →
Assignment of Assignor's Interest
Nov 15, 2005
From: ELAN PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTICS INC.
Reel/Frame 017230/0627 →
Assignment of Assignor's Interest
Dec 12, 2005
From: ELAN PHARMACEUTICALS, INC.
To: ACORDA THERAPEUTICS INC.
Reel/Frame 016871/0631 →
Grant of a Security Interest in Grantor's (Debtor's) Ownership Rights to Grantee (Secured Party)
Jan 27, 2006
From: ACORDA THERAPEUTICS, INC.
To: KING GEORGE HOLDINGS LUXEMBOURG IIA S.A.R.L.
Reel/Frame 017073/0562 →
Release of Security Interest
Jul 18, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 043034/0919 →